Search research articles
Contact Us
Filters
Showing results (51-60 of 229) with videos related to
Page
of 23
Sort By:
Archives of Pathology & Laboratory Medicine
|
January 3, 2012
Verification of performance specifications for a US Food and Drug Administration-approved molecular microbiology test: Clostridium difficile cytotoxin B using the Becton, Dickinson and Company GeneOhm Cdiff assay
Robert Schlaberg, Michael J Mitchell, Edward W Taggart, et al.
Advanced Drug Delivery Reviews
|
July 29, 2024
Drug delivery technologies for autoimmunity therapies
Ajay S Thatte, Jessica D Weaver, Ryan Pearson, et al.
Cancer Gene Therapy
|
April 23, 2021
Delivery technologies to engineer natural killer cells for cancer immunotherapy
Rakan El-Mayta, Zijing Zhang, Alex G Hamilton, et al.
Nature Reviews. Drug Discovery
|
January 10, 2019
Delivery technologies for cancer immunotherapy
Rachel S Riley, Carl H June, Robert Langer, et al.
Cancer Letters
|
May 18, 2019
Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy
Alvin J Mukalel, Rachel S Riley, Rui Zhang, et al.
American Journal of Medical Genetics. Part A
|
July 22, 2004
Germline mosaicism resulting in the transmission of severe hemophilia B from a grandfather with a mild deficiency
Jacqueline A Cutler, Michael J Mitchell, Mark P Smith, et al.
Technology
|
July 8, 2014
A microfluidic device to select for cells based on chemotactic phenotype
Saumendra Bajpai, Michael J Mitchell, Michael R King, et al.
Advanced Drug Delivery Reviews
|
September 21, 2020
Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy
Christian G Figueroa-Espada, Samuel Hofbauer, Michael J Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 8, 2014
TRAIL-coated leukocytes that kill cancer cells in the circulation
Michael J Mitchell, Elizabeth Wayne, Kuldeepsinh Rana, et al.
Nanoscale Horizons
|
October 20, 2025
Lipid nanoparticles for engineering next generation CAR T cell immunotherapy
Melgious Jin Yan Ang, Ann E Metzloff, Ajay S Thatte, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 229) with videos related to
Sort By:
Page
of 23
Archives of Pathology & Laboratory Medicine
|
January 3, 2012
Verification of performance specifications for a US Food and Drug Administration-approved molecular microbiology test: Clostridium difficile cytotoxin B using the Becton, Dickinson and Company GeneOhm Cdiff assay
Robert Schlaberg, Michael J Mitchell, Edward W Taggart, et al.
Advanced Drug Delivery Reviews
|
July 29, 2024
Drug delivery technologies for autoimmunity therapies
Ajay S Thatte, Jessica D Weaver, Ryan Pearson, et al.
Cancer Gene Therapy
|
April 23, 2021
Delivery technologies to engineer natural killer cells for cancer immunotherapy
Rakan El-Mayta, Zijing Zhang, Alex G Hamilton, et al.
Nature Reviews. Drug Discovery
|
January 10, 2019
Delivery technologies for cancer immunotherapy
Rachel S Riley, Carl H June, Robert Langer, et al.
Cancer Letters
|
May 18, 2019
Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy
Alvin J Mukalel, Rachel S Riley, Rui Zhang, et al.
American Journal of Medical Genetics. Part A
|
July 22, 2004
Germline mosaicism resulting in the transmission of severe hemophilia B from a grandfather with a mild deficiency
Jacqueline A Cutler, Michael J Mitchell, Mark P Smith, et al.
Technology
|
July 8, 2014
A microfluidic device to select for cells based on chemotactic phenotype
Saumendra Bajpai, Michael J Mitchell, Michael R King, et al.
Advanced Drug Delivery Reviews
|
September 21, 2020
Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy
Christian G Figueroa-Espada, Samuel Hofbauer, Michael J Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 8, 2014
TRAIL-coated leukocytes that kill cancer cells in the circulation
Michael J Mitchell, Elizabeth Wayne, Kuldeepsinh Rana, et al.
Nanoscale Horizons
|
October 20, 2025
Lipid nanoparticles for engineering next generation CAR T cell immunotherapy
Melgious Jin Yan Ang, Ann E Metzloff, Ajay S Thatte, et al.
Page
of 23